ArticleCartography and geographic information science2026
Drug and Substance Abuse Point of Interest (POI) Conflation and Spatial Attribute Enrichment Framework.
Article in Cartography and geographic information science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Point of Interest (POI) data is essential for accurate spatial analysis of pressing healthcare issues such as Drug and Substance Abuse (DSA). However, retrieving accurate healthcare POI information remains complicated. POI conflation integrates data from multiple sources to enhance spatial attribute quality and coverage. This study proposes a multi-step framework for healthcare POI conflation, including POI data collection from Location-Based Services (LBS), geographic and spatial attributes collection, calculating similarity across datasets, POI matching, spatial attributes enrichment, manual labeling, quality control, and deployment. We tested this framework on a DSA use case in California, USA. Our automated approach was able to detect 11,936 unique POIs related to this healthcare tag. Of the locations used for use case validation, 33% were common with the commercial benchmark POI dataset used by Safegraph. Out of the 11,936 total POIs, we were only able to find 4,535 (38%) that were not in the commercial benchmark dataset and relevant to the use case. Moreover, our results indicate that spatial attributes fill rates are 32% at the geometry building level and 98% at the Census block group (CBG) level. We conclude that using LBS can provide POIs with relevance and spatial attributes similar to commercial datasets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.